Dr. Simó Schwartz Jr. has been appointed as the new general director of the Blood and Tissue Bank, replacing Dr. Enric Argelagués, who leaves his position today, March 1, after 17 years in the management (1993 – 2002 and 2013 – 2021)...
Read moreVall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer
Nanomedicine has emerged as a potential therapy for pancreatic cancer, a disease with a 5-year survival rate as low as 5%. The international project NoCanTher was launched in 2016 to test the use of magnetic nanoparticles in treating locally...
Read moreA study by Vall d’Hebron suggests a new strategy for the treatment of colorectal cancer
The research group on CIBBIM-Nanomedicine, Drug Delivery and Targeting of the Vall d’Hebron Research Institute (VHIR) has recently participated in a study with the aim of finding a useful treatment to combat colorectal cancer, but also to...
Read moreCreated BSURE Medical, a new spin-off of the VHIR
The creation of BSURE Medical represents the culmination of the valuation and transfer strategy carried out by the VHIR Innovation Unit of a research project of which Dr. Jaume Alijotas Reig and Dr. Simo Schwartz Jr are the main researchers and...
Read moreFinal workshop of the Smart4Fabry project
More information
Read morePatented a peptide that allows faster internalization of drugs within cells and the design of more effective therapeutic nanoconjugates
The membrane of a cell is an effective barrier that makes it difficult to deliver molecules, such as therapeutic compounds, in a targeted manner. In recent years, various strategies have been developed to get the molecules inside the cell, but in...
Read moreThe potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles
Petra Gener , Patricia Gonzalez Callejo, Joaquín Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo & Simo Schwartz. The presence of highly resistant cancer stem cells (CSCs) within tumors as drivers of metastatic spread has been...
Read moreExtracellular Vesicles as Drug Delivery Systems in Cancer
Laia Hernandez-Oller 1 , Joaquin Seras-Franzoso 1, Fernanda Andrade 1,2, Diana Rafael 1,2, Ibane Abasolo 1,2 , Petra Gener 1,2,* and Simo Schwartz Jr. 1,2,* 1 Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre...
Read moreNovel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs
Andreia Almeida 1, Marco Araújo 2, Ramon Novoa-Carballal 3, Fernanda Andrade 4, Hugo Gonçalves 5, Rui L Reis 3, Marlene Lúcio 6, Simó Schwartz Jr 7, Bruno Sarmento 8 PMID: 32409071 DOI: 10.1016/j.msec.2020.110920 Abstract Chitosan was grafted...
Read moreSimvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease
Diana Hide 1, Mar Gil 2, Fernanda Andrade 3, Diana Rafael 4, Imma Raurell 5, Miren Bravo 6, Aurora Barberá 7, Jordi Gracia-Sancho 8, Víctor Vargas 9, Salvador Augustin 10, Joan Genescà 11, Simo Schwartz Jr 12, Maria Martell 13 PMID: 32681987 DOI...
Read moreThree researchers at VHIR receive a grant from the Spanish Association Against Cancer
The Spanish Association Against Cancer (AECC) presented today, within the framework of World Cancer Research Day, the resolution of the grants to promote research against cancer. Among the selected candidates, there are three researchers working...
Read moreCerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C viruses, alcoholism, metabolic diseases of the liver and exposure to certain toxins...
Read more